{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:40:49Z","timestamp":1788039649742,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["No.2023YFF1204700, branch No.2023YFF1204702"],"award-info":[{"award-number":["No.2023YFF1204700, branch No.2023YFF1204702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01145-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:45:18Z","timestamp":1766414718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatoid adenocarcinoma of the stomach and non-hepatoid alpha-fetoprotein-producing gastric cancer exhibit a high degree of molecular similarity"],"prefix":"10.1007","volume":"49","author":[{"given":"Liqiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaode","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"1145_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"A.P. Thrift, H.B. El-Serag, Burden of gastric cancer. Clin. Gastroenterol. Hepatol. 18, 534\u2013542 (2020)","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1145_CR2","doi-asserted-by":"crossref","unstructured":"M. Inoue, Epidemiology of gastric cancer-changing trends and global disparities. Cancers (Basel). 16, (2024)","DOI":"10.3390\/cancers16172948"},{"key":"1145_CR3","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"B. Han et al., Cancer incidence and mortality in China, 2022. J. Natl. Cancer Cent. 4, 47\u201353 (2024)","journal-title":"J. Natl. Cancer Cent."},{"key":"1145_CR4","doi-asserted-by":"publisher","first-page":"633916","DOI":"10.3389\/fonc.2021.633916","volume":"11","author":"R Xia","year":"2021","unstructured":"R. Xia, Y. Zhou, Y. Wang, J. Yuan, X. Ma, Hepatoid adenocarcinoma of the stomach: current perspectives and new developments. Front. Oncol. 11, 633916 (2021)","journal-title":"Front. Oncol."},{"key":"1145_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"I.D. Nagtegaal et al., The 2019 WHO classification of tumours of the digestive system. Histopathology. 76, 182\u2013188 (2020)","journal-title":"Histopathology"},{"key":"1145_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3748\/wjg.v19.i3.321","volume":"19","author":"JS Su","year":"2013","unstructured":"J.S. Su et al., Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J. Gastroenterol. 19, 321\u2013327 (2013)","journal-title":"World J. Gastroenterol."},{"key":"1145_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12876-023-02773-9","volume":"23","author":"L Li","year":"2023","unstructured":"L. Li et al., Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study. BMC Gastroenterol. 23, 142 (2023)","journal-title":"BMC Gastroenterol."},{"key":"1145_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/bjs.7081","volume":"97","author":"M Inoue","year":"2010","unstructured":"M. Inoue et al., Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer. Br. J. Surg. 97, 1056\u20131061 (2010)","journal-title":"Br. J. Surg."},{"key":"1145_CR9","doi-asserted-by":"publisher","first-page":"635537","DOI":"10.3389\/fonc.2021.635537","volume":"11","author":"X-X Kong","year":"2021","unstructured":"X.-X. Kong et al., The clinicopathological characteristics of Alpha-Fetoprotein-Producing adenocarcinoma of the Gastrointestinal Tract-A Single-Center retrospective study. Front. Oncol. 11, 635537 (2021)","journal-title":"Front. Oncol."},{"key":"1145_CR10","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1002\/cam4.5883","volume":"12","author":"Y Mei","year":"2023","unstructured":"Y. Mei, M. Li, J. Wen, X. Kong, J. Li, Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer. Cancer Med. 12, 12018\u201312033 (2023)","journal-title":"Cancer Med."},{"key":"1145_CR11","doi-asserted-by":"crossref","unstructured":"E.-B. Chen et al., Hepatoid adenocarcinoma of stomach: emphasis on the clinical relationship with alpha-fetoprotein-positive gastric cancer. BioMed Res. Internat. 6710428 (2019)","DOI":"10.1155\/2019\/6710428"},{"key":"1145_CR12","doi-asserted-by":"publisher","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","volume":"52","author":"Z Sondka","year":"2024","unstructured":"Z. Sondka et al., COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Res. 52, D1210\u2013D1217 (2024)","journal-title":"Nucleic Acids Res."},{"key":"1145_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"R. Cristescu et al., Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat. Med. 21, 449\u2013456 (2015)","journal-title":"Nat. Med."},{"key":"1145_CR14","doi-asserted-by":"publisher","first-page":"215803","DOI":"10.1016\/j.canlet.2022.215803","volume":"544","author":"YH Hong","year":"2022","unstructured":"Y.H. Hong et al., The EEF1AKMT3\/MAP2K7\/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer. Cancer Lett. 544, 215803 (2022)","journal-title":"Cancer Lett."},{"key":"1145_CR15","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1038\/s41388-021-01976-2","volume":"40","author":"Z Liu","year":"2021","unstructured":"Z. Liu et al., Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach. Oncogene. 40, 5705\u20135717 (2021)","journal-title":"Oncogene"},{"key":"1145_CR16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41416-023-02378-9","volume":"129","author":"K Ando","year":"2023","unstructured":"K. Ando et al., Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study). Br. J. Cancer. 129, 1032\u20131039 (2023)","journal-title":"Br. J. Cancer"},{"key":"1145_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13148-025-01829-9","volume":"17","author":"S Wang","year":"2025","unstructured":"S. Wang et al., LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations. Clin. Epigenetics. 17, 26 (2025)","journal-title":"Clin. Epigenetics"},{"key":"1145_CR18","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1002\/cjp2.343","volume":"10","author":"X Yang","year":"2024","unstructured":"X. Yang et al., Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases. J. Pathol. Clin. Res. 10, e343 (2024)","journal-title":"J. Pathol. Clin. Res."},{"key":"1145_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","volume":"22","author":"C Dumontet","year":"2023","unstructured":"C. Dumontet, J.M. Reichert, P.D. Senter, J.M. Lambert, A. Beck, Antibody-drug conjugates come of age in oncology. Nat. Rev. Drug Discov. 22, 641\u2013661 (2023)","journal-title":"Nat. Rev. Drug Discov"},{"key":"1145_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/cac2.12214","volume":"41","author":"Z Peng","year":"2021","unstructured":"Z. Peng et al., Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study. Cancer Commun. (Lond). 41, 1173\u20131182 (2021)","journal-title":"Cancer Commun. (Lond)"},{"key":"1145_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jclinpath-2017-204928","volume":"71","author":"M Fujimoto","year":"2018","unstructured":"M. Fujimoto et al., HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. J. Clin. Pathol. 71, 600\u2013607 (2018)","journal-title":"J. Clin. Pathol."},{"key":"1145_CR22","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/bjc.2015.367","volume":"113","author":"J Cai","year":"2015","unstructured":"J. Cai et al., FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt\/\u03b2-catenin signalling. Br. J. Cancer. 113, 1720\u20131729 (2015)","journal-title":"Br. J. Cancer"},{"key":"1145_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10120-016-0593-5","volume":"20","author":"S Yoshida","year":"2017","unstructured":"S. Yoshida et al., Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Gastric Cancer. 20, 136\u2013145 (2017)","journal-title":"Gastric Cancer"},{"key":"1145_CR24","doi-asserted-by":"publisher","first-page":"28857","DOI":"10.1038\/s41598-024-79688-2","volume":"14","author":"Sadaf","year":"2024","unstructured":"Sadaf et al., LATS2 and FAT4 as key candidate genes of Hippo pathway associated with the risk and progression of breast cancer: an in-silico approach. Sci. Rep. 14, 28857 (2024)","journal-title":"Sci. Rep."},{"key":"1145_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/0113892029300694240612081006","volume":"25","author":"Q Li","year":"2024","unstructured":"Q. Li, Y. Chu, Y. Yao, Q. Song, FAT4 mutation is related to tumor mutation burden and favorable prognosis in gastric cancer. Curr. Genomics. 25, 380\u2013389 (2024)","journal-title":"Curr. Genomics"},{"key":"1145_CR26","doi-asserted-by":"crossref","unstructured":"R. Wang et al., Prognostic implications of LRP1B and its relationship with the tumor-infiltrating immune cells in gastric cancer. Cancers (Basel). 15, (2023)","DOI":"10.3390\/cancers15245759"},{"key":"1145_CR27","doi-asserted-by":"crossref","unstructured":"I.H. Song, B. Ahn, Y.S. Park, D.H. Kim, S.M. Hong, Presence of RB1 or absence of LRP1B mutation predicts poor overall survival in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. Cancer Res. Treat. (2024)","DOI":"10.4143\/crt.2024.667"},{"key":"1145_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s10120-025-01594-x","volume":"28","author":"L Zan","year":"2025","unstructured":"L. Zan et al., Genomic landscape and potential therapeutic targets in alpha-fetoprotein-producing gastric cancer. Gastric Cancer. 28, 372\u2013383 (2025)","journal-title":"Gastric Cancer"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01145-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01145-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01145-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:45:19Z","timestamp":1766414719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01145-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1145"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01145-7","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study of human samples was performed according to the Declaration of Helsinki and Good Clinical Practice. The protocol of this research and the license for usage of clinical data were given by the Ethics Committee of Peking University Cancer Hospital and Institute (code 2024KT174). All patients signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}